Horizons in HIV Drug Development – What’s Past is Prologue

January 14, 2019

This white paper will begin with a profile of the historical and ongoing trial landscape and then delve into an analysis of drug development, with a focus on the novel MOAs that represent the first earnest attempt at a world where HIV-positive patients are able to live medication- free.